CancerIQ retweeted
Congratulations to our #CASTUS portfolio company, @CancerIQ, for being named one of the World's Best Digital Health Companies in 2024 by @Newsweek and @StatistaCharts! 🎉 Read full article: bit.ly/4b6tdBH
#ClevelandAvenue #NewsWeek #AheadOfCancer
CancerIQ retweeted
For #LynchSyndromeAwarenessDay this is your reminder that:
💠 Lynch syndrome is common (1:279 individuals)
💠 Lynch syndrome is actionable (increased surveillance/prevention options lead to better outcomes)
💠 Lynch syndrome is underdiagnosed (most people are not aware that they have it)
#ColorectalCancerAwarenessMonth
CancerIQ retweeted
Q&A: Partnering with providers for #cancer #prevention - @CancerIQ provides personalized care plans to help providers detect cancer early and prevent progression of the disease, says Feyi Ayodele, founder and CEO of CancerIQ. mobihealthnews.com/news/qa-p…
CancerIQ retweeted
The American Cancer Society Cancer Facts & Figures 2024 report is here. With breast, prostate, colorectal (ages 0-54), and cervical (ages 30-44) cancers on the rise, it's important to get screened. Hear more from @AmerCancerCEO.
Full report: amercancer.co/cff24
CancerIQ retweeted
New germline genetic testing guidelines: All women with breast cancer diagnosis under the age of 65 should be offered germline genetic testing. They don’t need to meet any additional criteria. Thank you @ASCO for the opportunity to draft these guidelines.
ascopubs.org/doi/full/10.120…
CancerIQ retweeted
1/ Welcome to #CGAIGCJS November Tweetorial on the Making #Genetic Testing Accessible (MAGENTA) Trial by #CGAIGC Comms Cttee member @asafmaoz
➡️The full article from @JAMAOnc can be found at 👉tinyurl.com/bdh5t6jv
🧵
#HereditaryGICancer
CancerIQ retweeted
Gastroenterologists are key to making a diagnosis of CRC but very few of them order genetic testing!
Is it time for gastroenterologists to take the lead?
Timely genetic testing improves outcomes and management
See our data at @CGAIGC #cgaigc23 @AmCollegeGastro @HHampel1
CancerIQ retweeted
15% of colorectal cancer patients who see a genetic counselor do not complete recommended genetic testing - @MarySmithsonMD breaks down geography and associated factors in these patients #CGAIGC23 @UABSurgery – at Las Vegas, NV
CancerIQ retweeted
Several Chicago biotech companies and health systems, including @CancerIQ and @NorthShoreWeb, are assisting President Joe Biden with his moonshot project that’s working to develop cures for cancer. chicagobusiness.com/health-c… – at Chicago, IL
CancerIQ retweeted
New @Found episode just dropped 🎙️Enabling equitable cancer prevention with Feyi Ayodele from CancerIQ tcrn.ch/3YN2h4P by @rebecca_szkutak and @dominicmadori
CancerIQ retweeted
#BreakingNews: #FightCRC, @BlueHats4colons, @ColonCancerCoal,
@blackingastro, @AmCollegeGastro, @AmerGastroAssn, and @ASGEendoscopy are standing united in support of #USPSTF's recommendations for #ColorectalCancer screening starting at age 45 for average-risk individuals, following @ACPIMPhysicians decision to recommend colorectal cancer screening starting at age 50.
fightcolorectalcancer.org/bl…
CancerIQ retweeted
"...talking about this not to scare you, but to raise awareness so maybe you can be tested/identify a #BRCA/other genetic mutation earlier. I would have screened more regularly MRI alt/w mammogram. MRI pick up cancers mammos miss." @JillMartin
today.com/video/jill-martin-… @TODAYshow
CancerIQ retweeted
8 Biotech Companies in Chicago Cultivating the City’s Life Sciences Scene buff.ly/3CRSJve @TempusLabs @CardiosenseInc @CancerIQ @abbvie @MAIABiotech @MedexusInc @icometrix
CancerIQ retweeted
NCCN: Genetic/Familial High-Risk Assessment: Colorectal (01.2023). @nccn expanding genetic testing to “Any Lynch related cancer” instead of colon and endometrial cancer as one of the testing criteria lynchsyndromeireland.com/202…
CancerIQ retweeted
Germline Genetic Testing After Cancer Diagnosis | Breast Cancer | JAMA | JAMA Network jamanetwork.com/journals/jam…
CancerIQ retweeted
Proud to be part of this effort and looking forward to increasing diversity in @PrecedeStudy to make early #PancreaticCancer detection accessible to all high-risk individuals.
🚨Important research now out from #PRECEDE w/ many contributors from #CGAIGC members incl Bryson Katona our president-elect
➡️#PancreaticCancer surveillance is critical to ⏬ pancreatic ca☠️
➡️Important that pancreatic ca surveillance studies enroll diverse🧑🤝🧑
#HereditaryGICancer
CancerIQ retweeted
We have unacceptably low rates of #Germline #GeneticTesting for patients with #cancer
🧬50% male #BreastCancer
🧬38% for #OvarianCancer
🧬5.6% #PancreaticCancer
… Guidelines recommend 100% for each of these sites 🫣
@JAMA_current
@AllisonKurian
jamanetwork.com/journals/jam…
CancerIQ retweeted
#Tumortesting misses #germlinevariants in 7-18% of #patients
(c/w Lincoln et al. @Invitae @JAMANetworkOpen jamanetwork.com/journals/jam…)
#Germline #genetictesting is gold standard to perform w/ #tumortesting to identify #PGVs
#DrBryanSchneider @IUMedSchool @ASCO #ASCO23
CancerIQ retweeted
The common 🪡 of #ASCO23 when it comes to germline testing is we aren’t doing enough, even as indications expand to make patient ID easier - we are getting caught up by process and we MUST do better for our patients @HHampel1 @ASCO @GeneticCouns @myriadgenetics
CancerIQ retweeted
Last selfie of #ASCO23 : with @feyiolopade @CancerIQ and @FayUCCancerCr . See you in Nara Japan in 2 weeks 🌏 for #MASCC23


































